HealthCare Global Enterprises Appoints Pankaj Gautam as Chief Information Officer

1 min read     Updated on 05 Feb 2026, 09:09 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

HealthCare Global Enterprises Limited has appointed Mr. Pankaj Gautam as Chief Information Officer, effective February 15, 2026, following Board approval on February 05, 2026. Gautam brings over 20 years of healthcare technology leadership experience from organizations including Rainbow Children's Hospitals, Glenhealth Works, and Apollo. He will join the company's Senior Management Personnel and lead digital health initiatives, technology strategy, and enterprise-wide transformation efforts.

powered bylight_fuzz_icon
31851588

*this image is generated using AI for illustrative purposes only.

Healthcare Global Enterprises Limited has announced a key addition to its senior management team with the appointment of Mr. Pankaj Gautam as Chief Information Officer. The appointment was approved by the Board of Directors at their meeting held on February 05, 2026, following recommendations from the Nomination and Remuneration Committee.

Appointment Details

The regulatory filing submitted under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirms that Mr. Gautam will join the company on or before February 15, 2026. He will form part of the Senior Management Personnel of HealthCare Global Enterprises Limited.

Parameter: Details
Position: Chief Information Officer
Effective Date: On or before February 15, 2026
Board Approval Date: February 05, 2026
Meeting Duration: 12:00 noon to 7:35 p.m. IST
Status: Senior Management Personnel

Professional Background

Mr. Pankaj Gautam brings extensive experience to his new role, with over 20 years of leadership experience in enterprise-wide transformation across major healthcare organizations. His expertise spans multiple critical areas of healthcare technology and operations.

Key Areas of Expertise

  • Digital health and technology strategy
  • Operational leadership in healthcare settings
  • Technology-enabled care model scaling
  • Integrated Health Delivery Networks
  • Enterprise HIS/EMR-EHR platforms

Previous Experience

Gautam has held leadership positions at several prominent healthcare organizations, where he has driven significant technological initiatives. His career includes tenures at Rainbow Children's Hospitals, Glenhealth Works, and Apollo, where he led high-impact transformation projects.

Initiative Type: Focus Areas
Telehealth Programs: Tele ICU, Tele ER solutions
Analytics: Healthcare data analytics
Care Solutions: Remote care delivery systems
Outcomes: Sustainable growth and improved care delivery

Regulatory Compliance

The appointment follows all regulatory requirements under SEBI LODR Regulations. The company has filed the necessary disclosures with both the National Stock Exchange of India Limited and BSE Limited, ensuring full compliance with listing obligations. The detailed information has been provided in accordance with Regulation 30(6) and the SEBI Master Circular dated January 30, 2026.

Healthcare Global Enterprises Shareholders Approve Consultancy Arrangement Variations with Dr B.S. Ajaikumar

2 min read     Updated on 22 Jan 2026, 03:52 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Healthcare Global Enterprises Limited shareholders approved variations to Dr B.S. Ajaikumar's consultancy arrangement through postal ballot with 98.32% favorable votes. The e-voting process saw 73.25% participation of total equity capital, with 238 members casting 10,32,84,703 valid votes. Results were declared on January 22, 2026, following scrutinizer V. Sreedharan's verification.

powered bylight_fuzz_icon
30622935

*this image is generated using AI for illustrative purposes only.

Healthcare Global Enterprises Limited has successfully concluded its postal ballot process, with shareholders providing overwhelming approval for variations to the consultancy arrangement with Dr B.S. Ajaikumar. The company announced the results on January 22, 2026, following the completion of the e-voting process and scrutinizer's report.

Voting Results and Participation

The postal ballot, conducted exclusively through e-voting, demonstrated strong shareholder participation and support. The voting statistics reveal significant engagement across all shareholder categories:

Category Shares Held Votes Polled Participation (%) Votes in Favor Votes Against Approval Rate (%)
Promoter and Promoter Group 8,99,23,122 7,61,59,095 84.69 7,61,59,095 0 100.00
Public-Institutions 3,03,36,422 2,63,44,813 86.84 2,48,60,396 14,84,417 94.37
Public-Non Institutions 2,07,48,093 7,80,795 3.76 5,33,233 2,47,562 68.29
Total 14,10,07,637 10,32,84,703 73.25 10,15,52,724 17,31,979 98.32

The resolution received approval from 98.32% of the valid votes cast, with 10,15,52,724 shares voting in favor and 17,31,979 shares voting against the proposal.

E-Voting Process Details

The postal ballot process was conducted in accordance with Section 110 of the Companies Act, 2013, and related regulations. Key process parameters included:

Parameter Details
Cut-off Date December 19, 2025
Notice Date December 17, 2025
Voting Period December 22, 2025 to January 21, 2026
Total Shareholders on Record 45,696
Members Participated 238
Scrutinizer V. Sreedharan, Partner, V. Sreedharan & Associates

The company sent the postal ballot notice exclusively via email to members whose email addresses were available, following MCA circulars related to COVID-19 guidelines. The voting was unblocked on January 21, 2026, at 5:00 PM for scrutiny.

Resolution Details and Approval

The ordinary resolution sought approval for variations to the consultancy arrangement with Dr B.S. Ajaikumar, in which the promoter and promoter group had declared interest. The resolution was categorized as an ordinary resolution requiring simple majority approval.

The scrutinizer's report, prepared by V. Sreedharan & Associates, confirmed the validity of the e-voting process and results. All votes cast through the electronic system were verified against the Register of Members and list of beneficiaries as of the cut-off date.

Regulatory Compliance and Documentation

The company has fulfilled all regulatory requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results have been communicated to both NSE and BSE, where the company's shares are listed under the symbols HCG and 539787 respectively.

The scrutinizer's report noted that 239 members initially participated in e-voting, with one abstention and minor adjustments resulting in 238 valid participants. Three members voted partially in favor and partially against the resolution, demonstrating the granular nature of the e-voting system.

More News on Healthcare Global Enterprises